FDA issues final guidance on CMC postapproval changes for biologics

Regulatory NewsRegulatory NewsBiologicsChemistry, Manufacturing and Controls (CMC)ComplianceNorth AmericaQuality Assurance and ControlRegulatory Intelligence/Policy